Sodium Chlorophyllin
Also known as: Sodium chlorophyllin, SCC, chlorophyllin, Sodium Copper Chlorophyllin
Overview
Sodium Copper Chlorophyllin (SCC) is a semi-synthetic, water-soluble derivative of chlorophyll, the green pigment found in plants. Unlike natural chlorophyll, SCC is produced by replacing the central magnesium ion with copper, enhancing its stability and bioavailability. It is widely used as a dietary supplement due to its potent antioxidant, anti-inflammatory, and potential chemopreventive properties. Beyond supplementation, SCC also finds applications as a food colorant and deodorizer. While not naturally occurring, its derivation from plant chlorophyll extracts makes it a bioavailable form of this essential plant pigment. Research into SCC's effects is ongoing, with a moderate level of maturity, primarily supported by in vitro and animal studies, and a growing body of human data.
Benefits
Sodium Copper Chlorophyllin (SCC) exhibits several promising benefits, primarily demonstrated in animal models. It has shown significant efficacy in reducing liver fibrosis and inflammation. For instance, an animal study indicated that oral SCC at 5 mg/kg significantly reduced liver fibrosis severity and inflammation induced by carbon tetrachloride in mice, leading to a reduction in mortality from 50% to 25% (p < 0.05). This suggests a strong potential for liver protection. Furthermore, SCC has demonstrated benefits in improving hematopoietic function. In a rat model of aplastic anemia, 100 mg/kg of SCC improved hemoglobin concentration, platelet counts, and bone marrow cellularity, in some cases outperforming cyclosporine A (CsA) (p < 0.05). This indicates a potential role in supporting blood cell production. Secondary effects include modulation of immune function, such as increasing regulatory T cells and reducing inflammatory cytokines like interferon-γ in aplastic anemia rats. While these findings are statistically significant in animal models, human clinical significance is yet to be established, as large-scale human trials are limited. The time course for benefits in animal studies typically ranged from several weeks to 8 weeks.
How it works
Sodium Copper Chlorophyllin (SCC) exerts its effects through multiple biological pathways. Its primary mechanism involves potent antioxidant activity, which helps reduce oxidative stress by neutralizing free radicals. SCC also demonstrates anti-inflammatory effects by modulating the production of various cytokines, thereby reducing systemic inflammation. In specific contexts, such as liver health, it inhibits fibrogenesis, preventing the excessive formation of fibrous tissue. Furthermore, SCC has immunomodulatory properties, influencing the immune system by altering T-cell subsets, including an increase in regulatory T cells. Molecularly, it has been shown to upregulate APO-1 (Fas receptor) expression in bone marrow mesenchymal stem cells and modulate the CD4/CD8 T-cell ratio. SCC and its copper-chlorin derivatives are absorbed in the gastrointestinal tract, allowing them to interact with various body systems, including hepatic, hematopoietic, and immune systems.
Side effects
The overall safety profile of Sodium Copper Chlorophyllin (SCC) is generally considered good, particularly in animal studies at tested doses. However, human safety data are limited, and comprehensive information on common, uncommon, or rare side effects is not well documented from controlled human trials. No major adverse effects have been reported at typical supplement doses in the limited human observations available. Regarding drug interactions, there are no well-documented interactions. However, theoretical caution is advised with immunosuppressants due to SCC's observed immunomodulatory effects in animal models. Contraindications are not firmly established, but caution is recommended for individuals who are immune-compromised or those currently undergoing immunosuppressive therapy. Specific safety data for vulnerable populations such as pregnant or lactating women, children, or the elderly are currently unavailable, and therefore, use in these groups should be approached with caution or avoided until more research is conducted.
Dosage
Optimal dosage ranges for Sodium Copper Chlorophyllin (SCC) in humans are not yet established due to limited clinical trials. Animal studies provide some insights, with effects observed at 5 mg/kg for liver fibrosis and 100 mg/kg for aplastic anemia models. However, these animal doses do not directly translate to human equivalent doses, and a wide range may be effective depending on the specific indication. The maximum safe dose for humans has not been defined. In animal studies, SCC was typically administered orally once daily for several weeks to achieve therapeutic effects. The standard form used in research is water-soluble sodium copper chlorophyllin. Its bioavailability is influenced by gastrointestinal metabolism, with copper-chlorin derivatives being the primary absorbed forms. No specific cofactors are identified as necessary for its absorption or efficacy.
FAQs
Is sodium chlorophyllin safe for daily use?
Animal studies suggest safety at tested doses. While human data are limited, no serious adverse effects have been widely reported, but long-term human safety is not fully established.
Can it be used for liver health?
Animal evidence supports its potential in reducing liver fibrosis and inflammation, suggesting a possible benefit for liver health, though human trials are needed.
Does it improve blood counts?
In animal models of aplastic anemia, it improved hemoglobin and platelet counts, indicating a potential role in supporting hematopoietic function.
How quickly do effects appear?
Animal studies show that effects typically appear after several weeks of consistent daily treatment.
Is it a natural compound?
No, it is a semi-synthetic derivative of natural chlorophyll, modified for enhanced stability and water solubility.
Research Sources
- https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.01671/full – This randomized controlled trial in mice investigated the effects of sodium chlorophyllin on carbon tetrachloride-induced liver fibrosis. The study found that sodium chlorophyllin at 5 mg/kg significantly reduced liver fibrosis, inflammation, and mortality, demonstrating its potential as a therapeutic agent for liver injury.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9007642/ – This study, conducted on a rat model of aplastic anemia, explored the effects of sodium copper chlorophyllin (SCC). It concluded that SCC at 100 mg/kg significantly improved hematopoietic function, including increased hemoglobin and platelet counts, and modulated immune responses, often outperforming cyclosporine A.
- https://onlinelibrary.wiley.com/doi/abs/10.1155/2022/6792866 – This research, also on a rat model of aplastic anemia, further detailed the immunomodulatory effects of sodium copper chlorophyllin. It showed that SCC improved hematopoietic function and modulated immune cell subsets, specifically increasing regulatory T cells and reducing inflammatory cytokines, contributing to its therapeutic potential.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10384064/ – This review synthesized existing human and animal data on the absorption of copper chlorin derivatives, including sodium chlorophyllin. It confirmed the absorption and bioavailability of these compounds in the gastrointestinal tract, highlighting that copper-chlorin derivatives are the primary absorbed forms, though comprehensive pharmacokinetic data are still needed.
